Lanreotide Acetate is used in some patients whose tumors cannot be removed by surgery, are locally advanced, or have metastasized. It is marketed under the trade name Somatuline. Reference standards of Lanreotide Acetate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Lanreotide Acetate
Catalogue No.:PA 12 82000
CAS :
Molecular Formula : C54H69N11O10S2•xC2H4O2
Molecular Weight : 1096.33.x(60.05)
(5R,8S,11S,14R,17S,20R)-14-((1H-Indol-3-yl)Methyl)-20-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-11-(4-aminobutyl)-17-(4-hydroxybenzyl)-8-isopropyl-7,10,13,16,19-pentaoxo-1,2,3-trithia-6,9,12,15,18-pentaazacyclohenicosane-5-carboxamide
Catalogue No.:PA 12 0821000
Molecular Formula : C54H69N11O10S3
Molecular Weight : 1128.39
Lanreotide Dimer 1
Catalogue No.:PA 12 0821001
Molecular Formula : C108H138N22O20S4
Molecular Weight : 2192.67
Lanreotide Dimer 2
Catalogue No.:PA 12 0821002
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
